Platelet function, coagulation and fibrinolysis in patients with previous coronary and cerebrovascular ischemic events

• Autor(a) principal: Barbosa, Carlos José Dornas Gonçalves
• Data de Publicação: 2019
• Outros Autores: Barreiros, Renata de Souza, Franci, André, Arantes, Flávia Bittar Brito, Furtado, Remo Holanda de Mendonça, Strunz, Célia Maria Cassaro, Rocha, Tânia Rúbia Flores da, Baracioli, Luciano Moreira, Ramires, José Antônio Franchini, Kalil-Filho, Roberto, Nicolau, José Carlos
• Tipo de documento: Artigo
• Idioma: eng
• Título da fonte: Clinics
• Texto Completo: https://www.revistas.usp.br/clinics/article/view/163016
• topic: Platelet Aggregation; Blood Coagulation; Fibrinolysis; Coronary Disease; Stroke

OBJECTIVES: Ischemic stroke (IS) or transient ischemic attack (TIA) history is present in 4-17% of patients with coronary artery disease (CAD). This subgroup of patients is at high risk for both ischemic and bleeding events. The aim of this study was to determine the role of platelet aggregability, coagulation and endogenous fibrinolysis in patients with CAD and previous IS or TIA. METHODS: A prospective case-control study that included 140 stable CAD patients divided into two groups: the CASE group (those with a previous IS/TIA, n=70) and the CONTROL group (those without a previous IS/TIA, n=70). Platelet aggregability (VerifyNow Aspirins and VerifyNow P2Y12s), coagulation (fibrinogen and thromboelastography by Reoroxs) and endogenous fibrinolysis (D dimer and plasminogen activator inhibitor-1) were evaluated. RESULTS: Patients in the CASE group presented significantly higher systolic blood pressure levels (135.84±16.09 vs 123.68±16.11, po0.01), significantly more previous CABG (25.71% vs 10%, p=0.015) and significantly higher calcium channel blocker usage (42.86% vs 24.29%, p=0.02) than those in the control group. In the adjusted models, low triglyceride values, low hemoglobin values and higher systolic blood pressure were significantly associated with previous IS/TIA (CASE group). Most importantly, platelet aggregability, coagulation and fibrinolysis tests were not independently associated with previous cerebrovascular ischemic events (CASE group). CONCLUSION: Platelet aggregability, coagulation and endogenous fibrinolysis showed similar results among CAD patients with and without previous IS/TIA. Therefore, it remains necessary to identify other targets to explain the higher bleeding risk presented by these patients.